EDMOND DE ROTHSCHILD HOLDING S.A. - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 2 filers reported holding ACASTI PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q1 2022$15,000
-40.0%
12,5000.0%0.00%
-100.0%
Q3 2021$25,000
-55.4%
12,500
-87.5%
0.00%0.0%
Q2 2021$56,000
-6.7%
100,0000.0%0.00%
-50.0%
Q1 2021$60,000100,0000.00%
Other shareholders
ACASTI PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 687,985$224,0000.02%
MITCHELL MCLEOD PUGH & WILLIAMS INC 45,000$15,0000.01%
Sterling Investment Advisors, Ltd. 40,000$13,0000.00%
OPPENHEIMER & CO INC 224,965$73,0000.00%
Renaissance Technologies 1,924,000$625,0000.00%
BANK OF AMERICA CORP /DE/ 2,500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 174,593$56,0000.00%
MILLENNIUM MANAGEMENT LLC 37,600$12,0000.00%
TORONTO DOMINION BANK 207$00.00%
View complete list of ACASTI PHARMA INC shareholders